List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 27 studies with search of: "Keratoconjunctivitis"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
Conditions: Keratoconjunctivitis;   Conjunctivitis
Interventions: Drug: FK506;   Drug: placebo
2 Active, not recruiting Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
Condition: Keratoconjunctivitis Sicca
Interventions: Drug: CF101;   Drug: Placebo
3 Completed Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: Pimecrolimus
4 Completed Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis
Condition: Vernal Keratoconjunctivitis
Interventions: Drug: Cyclosporine A 0,05% eye drop;   Drug: ketotifen fumarate 0.025% eye drops
5 Completed Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment
Condition: Vernal Keratoconjunctivitis
Interventions: Drug: Lactobacillus Rhamnosus GG;   Drug: placebo (sugar)
6 Recruiting A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: voclosporin ophthalmic solution
7 Completed Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis
Condition: Keratoconjunctivitis, Vernal
Intervention: Drug: N-acetyl-aspartyl-glutamate (NAAXIA Sine)
8 Completed Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
Conditions: Keratoconjunctivitis;   Conjunctivitis
Intervention: Drug: FK506
9 Completed Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops
Conditions: Keratoconjunctivitis Sicca;   Sjogren's Syndrome
Intervention: Drug: Cyclosporin A
10 Recruiting Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry Eyes
Condition: Keratoconjunctivitis Sicca
Interventions: Dietary Supplement: Hydroeyes;   Other: Inactive Capsule
11 Recruiting The Pathogenesis of Superior Limbic Keratoconjunctivitis
Condition: Superior Limbic Keratoconjunctivitis
Intervention:
12 Recruiting Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: AT01;   Drug: AT02;   Drug: AT03;   Drug: AT04
13 Completed Study of Rebamipide Eye Drops to Treat Dry Eye
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: Rebamipide
14 Completed Study of Rebamipide Eye Drops to Treat Dry Eye
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: Rebamipide
15 Completed Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
Conditions: Keratoconjunctivitis Sicca;   Sjogren's Syndrome;   Lupus Erythematosus, Systemic;   Arthritis, Rheumatoid;   Scleroderma, Systemic
Intervention: Drug: Ophthalmic Emulsion
16 Completed Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: cyclosporine ophthalmic emulsion 0.05%, artificial tears
17 Recruiting Goblet Cell Response and Dry Eye Symptoms After PRK and LASIK
Condition: Keratoconjunctivitis Sicca
Interventions: Procedure: PRK with conjunctival impression cytology before and after surgery;   Procedure: LASIK with conjunctival impression cytology before and after surgery
18 Completed Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points
Condition: Keratoconjunctivitis Sicca
Interventions: Drug: Systane Ocular Drops (OTC);   Drug: Placebo - Saline Drops
19 Recruiting Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
Conditions: Dry Eye Disease;   Keratoconjunctivitis Sicca
Interventions: Drug: Lotemax;   Drug: Restasis
20 Recruiting Effect of B-Cell Depletion in Patients With Primary Sjögren's Syndrome
Conditions: Primary Sjögren's Syndrome;   Xerostomia;   Hyposalivation;   Keratoconjunctivitis Sicca;   Fatigue
Interventions: Drug: MabThera (rituximab);   Drug: Rituximab, Mabthera

Previous Page Studies Shown (1-20) Next Page (21-27)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services